Geneos Wealth Management’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279K Buy
5,235
+651
+14% +$35K 0.01% 861
2025
Q4
$247K Sell
4,584
-394
-8% -$21.3K 0.01% 858
2025
Q3
$269K Sell
4,978
-686
-12% -$36.7K 0.01% 818
2025
Q2
$302K Sell
5,664
-13,457
-70% -$702K 0.01% 860
2025
Q1
$1M Buy
19,121
+16,039
+520% +$833K 0.01% 660
2024
Q4
$159K Buy
3,082
+1,363
+79% +$71.4K 0.01% 922
2024
Q3
$92.3K Buy
1,719
+233
+16% +$12.3K ﹤0.01% 989
2024
Q2
$76.2K Sell
1,486
-683
-31% -$34.8K ﹤0.01% 943
2024
Q1
$112K Sell
2,169
-1,266
-37% -$65.1K 0.01% 826
2023
Q4
$179K Buy
3,435
+1,513
+79% +$74.8K 0.01% 700
2023
Q3
$93.5K Sell
1,922
-1,308
-40% -$65.1K ﹤0.01% 896
2023
Q2
$163K Sell
3,230
-108
-3% -$5.49K 0.01% 725
2023
Q1
$171K Sell
3,338
-379
-10% -$19.2K 0.01% 689
2022
Q4
$184K Buy
3,717
+611
+20% +$29.9K 0.01% 647
2022
Q3
$149K Buy
3,106
+1,655
+114% +$84.6K 0.01% 687
2022
Q2
$74K Sell
1,451
-315
-18% -$16.4K ﹤0.01% 1116
2022
Q1
$96K Sell
1,766
-449
-20% -$25.5K ﹤0.01% 1109
2021
Q4
$131K Sell
2,215
-89
-4% -$5.3K 0.01% 1069
2021
Q3
$138K Sell
2,304
-23
-1% -$1.4K 0.01% 1025
2021
Q2
$140K Sell
2,327
-603,861
-100% -$36.2M 0.01% 1018
2021
Q1
$36.2M Buy
606,188
+19,113
+3% +$1.16M 1.01% 14
2020
Q4
$171K Buy
587,075
+585,026
+28,552% +$35.8M 0.01% 892
2020
Q3
$124K Sell
2,049
-322
-14% -$19.6K 0.01% 854
2020
Q2
$142K Sell
2,371
-2,470
-51% -$144K 0.01% 776
2020
Q1
$263K Buy
4,841
+1,706
+54% +$98.5K 0.02% 533
2019
Q4
$182K Sell
3,135
-2,086
-40% -$121K 0.01% 724
2019
Q3
$302K Sell
5,221
-3,220
-38% -$185K 0.02% 525
2019
Q2
$480K Sell
8,441
-6,696
-44% -$372K 0.03% 415
2019
Q1
$834K Buy
15,137
+530
+4% +$28.5K 0.06% 303
2018
Q4
$764K Sell
14,607
-13,024
-47% -$681K 0.06% 297
2018
Q3
$1.98M Buy
27,631
+4,667
+20% +$248K 0.13% 176
2018
Q2
$1.22M Buy
22,964
+970
+4% +$51.6K 0.1% 195
2018
Q1
$1.18M Buy
21,994
+13,480
+158% +$726K 0.1% 190
2017
Q4
$464K Buy
8,514
+4,856
+133% +$266K 0.04% 333
2017
Q3
$201K Buy
+3,658
New +$201K 0.02% 509
2016
Q4
Sell
-144
Closed -$8K 2071
2016
Q3
$8K Hold
144
﹤0.01% 1443
2016
Q2
$8K Sell
144
-1,156
-89% -$63.6K ﹤0.01% 1394
2016
Q1
$71K Buy
+1,300
New +$70.2K 0.01% 683

Other funds holding IGIB

Geneos Wealth Management's IGIB Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) stake by 14% in Q1 2026, buying an estimated $35K and bringing the position to 5,235 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #861.

Geneos Wealth Management first reported a position in IGIB in Q1 2016 and has held it in 38 quarters since. The position peaked at $36.2M in Q1 2021. 705 funds tracked by Wall St. Rank hold IGIB as of Q1 2026.

  • Geneos Wealth Management held 5,235 shares of iShares 5-10 Year Investment Grade Corporate Bond ETF worth $279K as of Q1 2026.
  • Geneos Wealth Management bought 651 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q1 2026, an estimated $35K.
  • iShares 5-10 Year Investment Grade Corporate Bond ETF made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #861 holding.
  • Geneos Wealth Management first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q1 2016 and has held it in 38 quarters since.
  • Geneos Wealth Management's iShares 5-10 Year Investment Grade Corporate Bond ETF position peaked at $36.2M in Q1 2021.
  • 705 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.